August, 2022 - Bench International

31 Aug Big tech helps scale healthcare access

Posted at 17:24h in Board Insights

Insight by: Debbie Lin The US, historically, has been characterized by vast inequities in health outcomes across socio-economic groups. Poor outcomes across diseases from tuberculosis to cardiovascular disease were found to be associated with basic social infrastructure problems such as poor housing, malnutrition and poor education...

31 Aug Being more ‘Customer-centric’ in Life Sciences

Posted at 13:58h in Board Insights

Insight by: Jon Warner Greater data connectivity, interoperability and increasing consumer engagement are key elements that are expected to shape the future of health. Within the next 10-15 years, the consumer—rather than health plans or providers—will determine when, where, and with whom he or she engages...

29 Aug An Update from the West Coast

Posted at 15:40h in Articles

Interview with Linda Sierra You work in two of the three top biotech markets in the U.S.; what trends are you seeing in San Diego and San Francisco? There is no debate it is a turbulent time in life science. Most CEOs are afraid they won't be...

05 Aug A Doctor a Day Keeps the Bad Apples Away

Posted at 17:54h in Board Insights

Insight by: Dave Whelan I often start talks by reminding the audience that I am neither a scientist nor a physician (and I can’t even play one on TV). That said, I continue, one of my gifts is the ability to help connect, translate, and even...

05 Aug Caveat Emptor – Terms to Avoid in your Outsourcing Deals

Posted at 17:43h in Board Insights

Insight by: Steve Martin According to a recent study produced by Zion Market Research, “the global Healthcare IT Outsourcing market…is estimated to grow to about USD 96.9 billion by 2028.” This would represent more than a $30B increase from the 2021 figures – nearly a 50%...

02 Aug Surviving the Life Sciences Funding Cliff

Posted at 13:46h in Articles

July 7, 2022 Denise DeMan Restructuring and ensuring the right talent is in place can help life sciences industry push through latest downward spiral. Market changes can occur quickly, but trends take time to emerge from the data. The same can be said for biotech and the life...